Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Greist

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Managed Care|March 21, 2009
Voice response system to measure healthcare costs: a STAR*D reportT Michael Kashner, Madhukar H Trivedi, Annie Wicker, et al.
International Clinical Psychopharmacology|October 27, 2011
A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episodeJames Michael Martinez, Wayne Katon, John H Greist, et al.
The Journal of Clinical Psychiatry|February 6, 2009
A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapySusan G Kornstein, David L Dunner, Adam L Meyers, et al.
Innovations in Clinical Neuroscience|December 19, 2014
Prospective assessment of suicidal ideation and behavior: an internet survey of pharmaceutical sponsor practices, Phillip B Chappell, Atul R Mahableshwarkar, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen, Christer Allgulander, Borwin Bandelow, et al.
The Journal of Clinical Psychiatry|October 6, 2007
A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatologyHeidi K Moore, Carroll W Hughes, James C Mundt, et al.
Innovations in Clinical Neuroscience|December 16, 2016
The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive DisorderAnthony L Vaccarino, Kenneth R Evans, Amir H Kalali, et al.
Innovations in Clinical Neuroscience|February 1, 2021
THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND TrialAnthony L Vaccarino, Amir H Kalali, Pierre Blier, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Managed Care|March 21, 2009
Voice response system to measure healthcare costs: a STAR*D reportT Michael Kashner, Madhukar H Trivedi, Annie Wicker, et al.
International Clinical Psychopharmacology|October 27, 2011
A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episodeJames Michael Martinez, Wayne Katon, John H Greist, et al.
The Journal of Clinical Psychiatry|February 6, 2009
A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapySusan G Kornstein, David L Dunner, Adam L Meyers, et al.
Innovations in Clinical Neuroscience|December 19, 2014
Prospective assessment of suicidal ideation and behavior: an internet survey of pharmaceutical sponsor practices, Phillip B Chappell, Atul R Mahableshwarkar, et al.
CNS Spectrums|February 10, 2004
WCA recommendations for the long-term treatment of social phobiaMichael Van Ameringen, Christer Allgulander, Borwin Bandelow, et al.
The Journal of Clinical Psychiatry|October 6, 2007
A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatologyHeidi K Moore, Carroll W Hughes, James C Mundt, et al.
Innovations in Clinical Neuroscience|December 16, 2016
The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive DisorderAnthony L Vaccarino, Kenneth R Evans, Amir H Kalali, et al.
Innovations in Clinical Neuroscience|February 1, 2021
THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND TrialAnthony L Vaccarino, Amir H Kalali, Pierre Blier, et al.
Pageof 4